| 英文别名 |
1,3,5(10)-ESTRATRIEN-17-ALPHA-ETHYNYL-3,6-ALPHA, 17-BETA-TRIOL;6β-Hydroxy Ethynyl Estradiol;Ethinylestradiol;ETHYNYLESTRADIOL IMPURITY F (6-BETA-HYDROXY ETHYNYLESTRADIOL);6Beta-Hydroxy Ethynyl Estradiol;A-Hydroxy Ethynyl Estradiol;Ethinylestradiol Imp. F (Pharmeuropa): 19-Nor-17a-pregna-1,3,5(10)-trien-20-yne-3,6b,17-triol(6b-Hydroxyethinylestradiol);Ethinylestradiol impurity F;6ss-Hydroxy-ethynylestradiol;ETHINYLESTRADIOL IMPURITY F [EP IMPURITY];Ethynyl Estradiol Impurity;F96981;ETHINYLESTRADIOL IMPURITY F (EP IMPURITY);6 beta -Hydroxy Ethynyl Estradiol;19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,6beta,17-triol;1,3,5(10)-ESTRATRIEN-17-alpha-ETHYNYL-3,6-alpha, 17-beta-TRIOL;19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,6beta,17-triol (6beta-Hydroxyethinylestradiol);6.BETA.-HYDROXY-ETHINYL ESTRADIOL;CHEMBL1627665;SCHEMBL3947959;19-Norpregna-1,3,5(10)-trien-20-yne-3,6,17-triol, (6beta,17alpha)-;6b-Hydroxy Ethynyl Estradiol;6beta-Hydroxy-ethinyl estradiol;Ethinylestradiol specified impurity F [EP];DTXCID10127358;6beta-Hydroxy Ethynyl Estradiol;Ethinylestradiol Imp. F (EP); 19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,6beta,17-triol; 6beta-Hydroxyethinylestradiol; Ethinylestradiol Impurity F;(6R,8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,6,17-triol;G1W6D0O0CW;19-NORPREGNA-1,3,5(10)-TRIEN-20-YNE-3,6,17-TRIOL, (6.BETA.,17.ALPHA.)-;1,3,5(10)-Estratrien-17-alpha-ethynyl-3,6-alpha,17-beta-triol;(6R,8R,9S,13S,14S,17R)-17-Ethynyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,6,17-triol;Ethinylestradiol impurity F [EP];Ethinylestradiol specified impurity F;UNII-G1W6D0O0CW;AKOS032958170;56324-28-8;19-NOR-17.ALPHA.-PREGNA-1,3,5(10)-TRIEN-20-YNE-3,6.BETA.,17-TRIOL;6beta-Hydroxy-ethinylestradiol;Q27278624;DTXSID80204867;6.BETA.-HYDROXY-ETHINYLESTRADIOL |
